Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study
J. Coresh,C. Ndumele,R. Blumenthal,Dan Wang,R. Florido,A. Folsom,C. Ballantyne,Vijay Nambi,J. Echouffo-Tcheugui,G. Heiss,E. Selvin,L. Kwak,K. Matsushita,L. Loehr,C. Hamo
DOI: https://doi.org/10.1161/JAHA.121.021583
2022-02-12
Abstract:There is an urgent need to improve heart failure (HF) prevention. Global cardiovascular health, as reflected by Life’s Simple 7, is linked to incident HF.1,2 However, the extent to which HF incidence might be mitigated by simultaneously optimizing the modifiable HF risk factors of hypertension, diabetes, and obesity has not been rigorously quantified. ARIC (Atherosclerosis Risk in Communities) study data have been made publicly available through the National Heart, Lung, and Blood Institute Biological Specimen and Data Repository Information Coordinating Center and can be accessed at (https:// bioli ncc.nhlbi.nih.gov/home/). We performed a prospective analysis of 13 313 participants in the ARIC study (mean age, 57 years, 55% women, 24% Black) without prevalent HF at cohort Visit 2 (1990– 1992). The ARIC protocol was approved by the Institutional Review Board associated with each field center and all participants provided informed consent. We examined the association of comprehensive risk factor control with incident HF through December, 31 2018. Incident HF was defined as hospitalization or death related to HF using International Classification of Diseases, Ninth and Tenth Revisions (ICD9 and ICD10) codes (ICD9 code 428 or ICD10 code I50). The primary exposures were Visit 2 measures of body mass index (BMI), mean systolic blood pressure (SBP), and hemoglobin A1C (HbA1C). We categorized each risk factor as absent, controlled, mildtomoderately uncontrolled, or severely uncontrolled. Levels of risk factor control were defined among individuals with hypertension and/or diabetes. Hypertension was defined as SBP ≥130 mm Hg, diastolic blood pressure ≥80 mm Hg, and/or selfreported use of antihypertensive medications. Diabetes was defined as a fasting blood glucose ≥126 mg/dL, nonfasting blood glucose ≥200 mg/dL, selfreported physician diagnosis of diabetes, selfreported use of diabetes medications, and/or HbA1C ≥6.5%. Having all “controlled” risk factors was defined as SBP <130 mm Hg for those with hypertension, HbA1C <7% for those with diabetes and BMI <30 kg/m2 (those with BMI <18.5 kg/m2 excluded). Severely uncontrolled risk factors were defined as BMI ≥35 kg/m2, SBP ≥160 mm Hg, and HbA1C ≥8%. Intermediate risk factor levels were considered mildtomoderately controlled. We categorized individuals as: absent risk factors, all controlled, 1 mildtomoderately uncontrolled, 2 to 3 mildtomoderately uncontrolled, 1 severely uncontrolled, or 2 to 3 severely uncontrolled. We constructed Kaplan– Meier cumulative survival curves (with proportional hazards assumption met) and
Medicine